new
   What are the Indications for Tebipenem P Granules (Tebipenem)?
503
Dec 12, 2025

Tebipenem P Granules (Tebipenem) is an oral carbapenem antibiotic formulated as fine granules specifically for pediatric use. Its active ingredient is tebipenem pivoxil, which exerts bactericidal effects by inhibiting bacterial cell wall synthesis.

What are the Indications for Tebipenem P Granules (Tebipenem)?

Pneumonia

It is indicated for the treatment of pulmonary infections caused by tebipenem-susceptible Streptococcus pneumoniae (including penicillin-resistant and erythromycin-resistant strains), Haemophilus influenzae (including ampicillin-resistant strains), and Moraxella catarrhalis.

Clinical trials have shown that its efficacy rate in pediatric pneumonia reaches 98.3%, with particularly significant antibacterial activity against drug-resistant Streptococcus pneumoniae.

Otitis Media

It has strong inhibitory effects on common pathogens of otitis media, such as Streptococcus pneumoniae, Haemophilus influenzae, and Streptococcus pyogenes.

Relevant research reports indicate that the clinical efficacy rate for children with otitis media is 98.0%, and the bacterial eradication rate is close to 100%.

Paranasal Sinusitis

It is suitable for mild to moderate sinus infections, especially for cases where conventional antibiotic therapy has poor efficacy.

It should be particularly noted that this drug is a carbapenem antibiotic with a special clinical positioning. It should only be used when other antibacterial drugs are ineffective, and its use must strictly comply with the results of etiological testing.

Specifications and Properties of Tebipenem P Granules (Tebipenem)

Specification Composition

Each 1 gram of granules contains 100 mg of tebipenem pivoxil (calculated by potency).

Excipients include 16 components such as microcrystalline cellulose, hydroxypropyl cellulose, hypromellose, talc, and ethylcellulose, with additional aspartame (containing phenylalanine) and vanillin as flavoring agents.

The packaging is available in 50g/bottle, 100g/bottle, and divided packaging of 0.5g×120 sachets.

Physicochemical Properties

Dosage form: Orange to light red fine granules.

Odor: Has an aromatic fragrance.

Solubility: The active ingredient is readily soluble in methanol and acetonitrile, and extremely insoluble in water.

This formulation balances pediatric medication compliance and drug stability, and its sweet and fragrant taste can reduce young children’s resistance to taking the medicine.

Storage Methods for Tebipenem P Granules (Tebipenem)

Storage Conditions

This product should be stored in a sealed container at room temperature, away from moisture and high-temperature environments.

The bottle cap should be tightly fastened immediately after opening, and the divided sachets should only be opened at the time of administration.

Validity Period and Supervision

The validity period is 3 years from the date of manufacture.

It is a prescription drug and must be used with a doctor’s prescription.

Attention should be paid to moisture protection; divided sachets that are not taken in a timely manner should be discarded.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
RELATED ARTICLES
Dosage and Administration, Recommended Dose of Elacestrant (Orserdu)

Elacestrant (Orserdu) is a selective estrogen receptor degrader (SERD), which provides an important treatment option...

Friday, December 19th, 2025, 11:49
What Are the Indications for Elacestrant (Orserdu)?

Elacestrant (Orserdu) is a novel endocrine therapy agent that demonstrates significant value in the treatment of...

Friday, December 19th, 2025, 11:40
What Are the Purchase Channels for Elacestrant (Orserdu)?

With the advancement of medical technology, elacestrant (Orserdu), a targeted drug for breast cancer with specific...

Friday, December 19th, 2025, 11:38
Adverse Reactions of Capmatinib (Tabrecta)

Capmatinib (Tabrecta) is a highly selective MET inhibitor indicated for the treatment of patients with advanced...

Friday, December 19th, 2025, 11:35
RELATED MEDICATIONS
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved